Main Article Content

Abstract

Ultraviolet light causes photodamaged skin leading to photoaging skin. Ultraviolet-B (UV-B) causes epidermal keratinocyte apoptosis, namely sunburn cell, through apoptotic intrinsic pathway. Erythropoietin (EPO) has a role in cytoprotection in various tissues but its role to epidermal skin is not clear yet. This study was designed pretest-posttest control group design. Thirty two male mice Mus musculus, strain Balbc, were divided into control and treatment group, 16 mice each group. All mice were exposured by UV-B light 16mJ/cm2, distance 30 cm, duration 90 seconds, for 3 consecutive days. Four mice each group were randomly sacrificed as pretest data. The control mice were given aquadest subcutaneous injection 0.1 mL, and treatment mice were given EPO subcutaneous injection  0.1 mL (100 IU/kg BW). UVB were given everyday with same protocol above. Treatments were given 4 times, interval 3 days. All mice were sacrificed to examine sunburn cells. Data were performed as mean ± SD and analyzed by t-test using SPSS 17.0 with significant value p<0.05. Sunburn cells of pretest control were 25.00 ± 4.85% and treatment group were 24.83 ± 5.15%. Sunburn cells significantly decreased (p=0.002) in treatment group (31.5 ± 9.39%) than control (50.83 ± 6.70%). UV-B causes sunburn cells formation. EPO inhibits apoptosis through increasing NO production and eNOS expression, inhibiting caspase and proinflammatory cytokines, and increasing antiapoptotic protein. EPO has a role in skin apoptosis inhibition which is shown by decreased sunburn cells

Keywords

Ultraviolet B erythropoietin sunburn cell photodamaged skin keratinocyte

Article Details

How to Cite
Suyono, H., Sanjaya, K., & Susanti, D. (2020). The Role of Antiapoptotic Erythropoietin on Ultraviolet B-Induced Photodamaged Skin Through Inhibition of Sunburn Cells. Folia Medica Indonesiana, 56(2), 114–117. https://doi.org/10.20473/fmi.v56i2.21229

References

  1. Boonstra A, van Oudenaren A, Barendregt B, et al (2000). UVB irradiation modulates systemic immune responses by affecting cytokine production of antigen-presenting cells. International Immunology 12, 1531-1538
  2. Burger D, Lei M, Morphet NG, et al (2006). Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovascular Research 72, 51-59
  3. Galeano M, Altavilla D, Cucinotta D, et al (2004). Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 53, 2509-2517
  4. Hamed S, Ullmann Y, Masoud M, et al (2010). Topical erythropoietin promotes wound repair in diabetic rats. Journal of Investigative Dermatology 130, 287-294
  5. Haroon Z.A, Amin K, Jiang X, et al (2003). A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol 163, 993-1000
  6. Joshi D, Tsui J, Ho TK, et al (2010). Review of the role erythropoietin in critical leg ischemia. Angiology 61, 541-550
  7. Lapin T (2003). The cellular biology of erythropoietin receptors. The Oncologist 8, 15-18
  8. Li Y, Takemura G, Okada H, et al (2006). Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovascular Research 71, 684-694
  9. Maiese K, Chong Z. Z, Hou J, et al (2008). Erythropoietin and oxidative stress. Curr Neurovasc Res 5, 125-142
  10. Paschos N, Lykissas M.G, Beris AE (2008). The role of erythropoietin as an inhibitor of tissue ischemia. Int J Biol Sci 4, 161-165
  11. Pradhan S, Kim HK, Thrash CJ, et al (2008). A critical role for proapoptotic protein bid in ultraviolet-induced immune suppression and cutaneous apoptosis. J Immunol 181, 3077-3088
  12. Raj D, Brash D.E, Grossman D (2006). Keratinocyte apoptosis in epidermal development and disease. J Invest Dermatol 126, 243-257
  13. Rigel DS, Weiss RA, Lim HW, et al (2004). Photoaging. Canada, Marcel Dekker Inc., p 34
  14. Sharples EJ, Patel N, Brown P, et al (2004). Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 15, 2115-2124
  15. Smith K. J, Bleyer AJ, Little WC, et al (2003). The cardiovascular effects of erythropoietin. Cardiovascular Research 59, 538-548
  16. Vorobiov M, Malki M, Schnaider A, et al (2008). Erythropoietin Prevents Dyalisis Fluid-Induced Apoptosis of Mesothelial Cells. Perit Dial Int, 28(6), 648-654